Bifidobacterium-based oral vaccine enhances anti-tumor immunity in clinical study
A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity.
14 Jul 13:16 · News-Medical
last updated on 14 Jul 16:08